Clinical and Biologic Effects of the Angiopoietin 1/2 Neutralizing Peptibody Trebananib (AMG 386) in Acute Myeloid Leukemia Patients
Titel:
Clinical and Biologic Effects of the Angiopoietin 1/2 Neutralizing Peptibody Trebananib (AMG 386) in Acute Myeloid Leukemia Patients
Auteur:
S, Wang Eunice J, Fetterly Gerald William, Brady Wei, Tan Jessica, Greene Allison, Gaudy E, Vigil Carlos H, Mendler Jason W, Becker Michael Kristen, O'Dwyer Jane, Liesveld Meir, Wetzler